Position in OGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,490,994
-$3,518,473 QoQ
Shares Held
183,973
-81.7% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#104
of 626 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026M&G PLC holds $1,479,850,248 across 11 Drug Manufacturers - General names. OGN ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
4,482,712 | $850,011,848 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
5,292,229 | $304,938,234 | |
| 3 | ABBV |
AbbVie Inc.
|
579,447 | $145,812,043 | |
| 4 | AMGN |
Amgen Inc
|
289,819 | $104,949,256 | |
| 5 | MRK |
Merck & Co., Inc.
|
210,965 | $27,109,002 | |
| 6 | JNJ |
Johnson & Johnson
|
52,505 | $13,334,694 | |
| 7 | PFE |
Pfizer Inc
|
418,626 | $10,080,514 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
78,527 | $9,921,101 |
All Filings in OGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,490,994 | 183,973 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $6,009,467 | 1,003,250 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,114,877 | 992,312 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $10,069,424 | 942,830 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $8,398,697 | 867,634 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,528,240 | 371,272 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,062,954 | 272,316 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,905,619 | 204,162 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $4,049,913 | 195,648 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $3,187,652 | 169,556 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||